Literature DB >> 21622257

Lactoferrin and cancer in different cancer models.

Jessica A Gibbons1, Rupinder K Kanwar, Jagat R Kanwar.   

Abstract

Lactoferrin (Lf) is a multifunctional protein and an essential element of innate immunity. Cancer is a major killer in today's world accounting for around 13% of all deaths according to the World Health Organisation (W.H.O.). The five most common forms of cancer include lung, colorectal, stomach, liver and breast cancer. Lactoferrin is a natural forming iron-binding glycoprotein with antibacterial, antioxidant and anti-carcinogenic effects. It is produced in exocrine glands and is secreted in many external fluids as a first line of defence. Lactoferrin also has the capacity to induce apoptosis and inhibit proliferation in cancer cells as well as restore white and red blood cell levels after chemotherapy. This review focuses on the therapeutic effect bovine sourced lactoferrin has on various forms of cancer in various models. It also focuses on the benefits of 3D in vitro cell culture. 3D cell culture has vast advantages over 2D models including demonstration of realistic therapeutic results and heightened resistance that 2D models fail to display.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622257     DOI: 10.2741/212

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  21 in total

1.  Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes.

Authors:  Yanhong Zhou; Wei Wang; Danwei Zheng; Shuping Peng; Wei Xiong; Jian Ma; Zhaoyang Zeng; Minghua Wu; Ming Zhou; Juanjuan Xiang; Bo Xiang; Xiaoling Li; Xiayu Li; Guiyuan Li
Journal:  Med Oncol       Date:  2011-10-20       Impact factor: 3.064

2.  Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer.

Authors:  Gengqiu Luo; Yanhong Zhou; Wei Yi; Hong Yi
Journal:  Oncol Lett       Date:  2015-03-03       Impact factor: 2.967

3.  Expression levels of JNK associated with polymorphic lactotransferrin haplotypes in human nasopharyngeal carcinoma.

Authors:  Gengqiu Luo; Yanhong Zhou; Wei Yi; Hong Yi
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

Review 4.  Chimeric aptamers in cancer cell-targeted drug delivery.

Authors:  Jagat R Kanwar; Kislay Roy; Rupinder K Kanwar
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-09-28       Impact factor: 8.250

5.  Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer.

Authors:  Jessica A Gibbons; Jagat R Kanwar; Rupinder K Kanwar
Journal:  BMC Cancer       Date:  2015-05-22       Impact factor: 4.430

6.  Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy.

Authors:  Tarek M Moastafa; Alaa El-Din Elsayed El-Sissy; Gehan K El-Saeed; Mai Salah El-Din Koura
Journal:  Int Sch Res Notices       Date:  2014-10-28

Review 7.  Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.

Authors:  Manny D Bacolod; Swadesh K Das; Upneet K Sokhi; Steven Bradley; David A Fenstermacher; Maurizio Pellecchia; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2015-05-23       Impact factor: 6.242

8.  Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.

Authors:  Kislay Roy; Yogesh S Patel; Rupinder K Kanwar; Rangam Rajkhowa; Xungai Wang; Jagat R Kanwar
Journal:  Int J Nanomedicine       Date:  2015-12-21

9.  Sex differences in the human peripheral blood transcriptome.

Authors:  Rick Jansen; Sandra Batista; Andrew I Brooks; Jay A Tischfield; Gonneke Willemsen; Gerard van Grootheest; Jouke-Jan Hottenga; Yuri Milaneschi; Hamdi Mbarek; Vered Madar; Wouter Peyrot; Jacqueline M Vink; Cor L Verweij; Eco J C de Geus; Johannes H Smit; Fred A Wright; Patrick F Sullivan; Dorret I Boomsma; Brenda W J H Penninx
Journal:  BMC Genomics       Date:  2014-01-17       Impact factor: 3.969

10.  Identification of unprecedented anticancer properties of high molecular weight biomacromolecular complex containing bovine lactoferrin (HMW-bLf).

Authors:  Fawzi Ebrahim; Jayanth Suryanarayanan Shankaranarayanan; Jagat R Kanwar; Sneha Gurudevan; Uma Maheswari Krishnan; Rupinder K Kanwar
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.